デュロキセチン投与後に抗利尿ホルモン不適合分泌症候群をきたした慢性腰痛症の1例
「緒言」抗利尿ホルモン不適合分泌症候群(syndrome of inappropriate antidiuretic hormone secretion: SIADH)は, 抗利尿ホルモン(antidiuretic hormone: ADH)のバソプレシン作用が過剰となることで腎集合管における自由水の再吸収が促進され, 低Na血症を生じる病態である. 臨床症状は脳浮腫や頭痛, 嘔気・嘔吐, 傾眠などの中枢神経症状を伴うことが多く, 適切な治療が行われない場合は死に至ることもある. SIADHの代表的な原因として, 薬剤性, 肺疾患, 悪性腫瘍が挙がる. 入院患者のうち, SIADHと診断された...
Saved in:
| Published in | 医療薬学 Vol. 50; no. 4; pp. 153 - 159 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | Japanese |
| Published |
一般社団法人日本医療薬学会
10.04.2024
日本医療薬学会 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1346-342X 1882-1499 |
| DOI | 10.5649/jjphcs.50.153 |
Cover
| Abstract | 「緒言」抗利尿ホルモン不適合分泌症候群(syndrome of inappropriate antidiuretic hormone secretion: SIADH)は, 抗利尿ホルモン(antidiuretic hormone: ADH)のバソプレシン作用が過剰となることで腎集合管における自由水の再吸収が促進され, 低Na血症を生じる病態である. 臨床症状は脳浮腫や頭痛, 嘔気・嘔吐, 傾眠などの中枢神経症状を伴うことが多く, 適切な治療が行われない場合は死に至ることもある. SIADHの代表的な原因として, 薬剤性, 肺疾患, 悪性腫瘍が挙がる. 入院患者のうち, SIADHと診断された555例の原因を調査した先行研究では, 特発性15.9%, 薬剤性26.5%, 肺疾患12.3%, 中枢神経系疾患7.2%, 悪性腫瘍27.7%, 疼痛や嘔気由来10.4%と報告されている. |
|---|---|
| AbstractList | 「緒言」抗利尿ホルモン不適合分泌症候群(syndrome of inappropriate antidiuretic hormone secretion: SIADH)は, 抗利尿ホルモン(antidiuretic hormone: ADH)のバソプレシン作用が過剰となることで腎集合管における自由水の再吸収が促進され, 低Na血症を生じる病態である. 臨床症状は脳浮腫や頭痛, 嘔気・嘔吐, 傾眠などの中枢神経症状を伴うことが多く, 適切な治療が行われない場合は死に至ることもある. SIADHの代表的な原因として, 薬剤性, 肺疾患, 悪性腫瘍が挙がる. 入院患者のうち, SIADHと診断された555例の原因を調査した先行研究では, 特発性15.9%, 薬剤性26.5%, 肺疾患12.3%, 中枢神経系疾患7.2%, 悪性腫瘍27.7%, 疼痛や嘔気由来10.4%と報告されている. |
| Author | 小林, 佳代 奥川, 寛 中村, 茂 小池, 淳平 土手, 賢史 小林, 由佳 |
| Author_xml | – sequence: 1 fullname: 奥川, 寛 organization: 社会福祉法人京都社会事業財団 京都桂病院 薬剤科 – sequence: 1 fullname: 小林, 由佳 organization: 社会福祉法人京都社会事業財団 京都桂病院 薬剤科 – sequence: 1 fullname: 小林, 佳代 organization: 社会福祉法人京都社会事業財団 京都桂病院 薬剤科 – sequence: 1 fullname: 土手, 賢史 organization: 社会福祉法人京都社会事業財団 京都桂病院 薬剤科 – sequence: 1 fullname: 小池, 淳平 organization: 社会福祉法人京都社会事業財団 京都桂病院 循環器内科 – sequence: 1 fullname: 中村, 茂 organization: 社会福祉法人京都社会事業財団 京都桂病院 循環器内科 |
| BookMark | eNo1UF1rE0EUHaQFa9pHf8bG-d6dN6VoFQK-VPBtmMzOml2STditD751u7QJsZUiSCh5KBRFSlEKfQkI8cdMdmP_RSdW4XLOhXvuOZf7CKyl_dQA8BjBJuNUPEmSQUfnTQabiJEHYAMFAfYQFWLN9YRyj1D89iHYyvO4DSFBiCMmNkBuy6Etv9nyhz1w9cuWhS1v6vGXxexTNT-2xVU9nlSjy-r6ty2ntryy5YUTLGYnt8VldTqqRkf1zfFyMqz2z5bzr_bgsy1ObHFui4nD-vCi3v_-5_B6OZk6jS1-osX84yZYj1Q3N1v_uAHevHi-u_3Sa73eebX9rOUlmAfIEyYKQwGhCHzjY8GCiPmRDlDojoeY0CBSodFc8xDrdlsZjbFWgiPNoK84D0gD7Nz79kwYa9Xtp904NTLpv89SlyvDNht0VNaTGGIqIWQQrohI6F64AkGJzyFFzunpvVOS76l3Rg6yuKeyD1Jle7HuOsu_z5cMSrqC1fr_kXYJMlHkDhA3p1I |
| ContentType | Journal Article |
| Copyright | 日本医療薬学会 |
| Copyright_xml | – notice: 日本医療薬学会 |
| CorporateAuthor | 循環器内科 社会福祉法人京都社会事業財団 京都桂病院 薬剤科 |
| CorporateAuthor_xml | – name: 循環器内科 – name: 社会福祉法人京都社会事業財団 京都桂病院 薬剤科 |
| DOI | 10.5649/jjphcs.50.153 |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1882-1499 |
| EndPage | 159 |
| ExternalDocumentID | db5pharm_2024_005004_003_0153_01594376041 article_jjphcs_50_4_50_153_article_char_ja |
| GroupedDBID | .LE 5GY ALMA_UNASSIGNED_HOLDINGS KQ8 MOJWN RJT |
| ID | FETCH-LOGICAL-j2681-9efdd900987e72958f57fc81d31102348fadec6c6d2cbbaec22ca961c507a6683 |
| ISSN | 1346-342X |
| IngestDate | Thu Jul 10 16:14:16 EDT 2025 Wed Sep 03 06:30:25 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 4 |
| Language | Japanese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j2681-9efdd900987e72958f57fc81d31102348fadec6c6d2cbbaec22ca961c507a6683 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/jjphcs/50/4/50_153/_article/-char/ja |
| PageCount | 7 |
| ParticipantIDs | medicalonline_journals_db5pharm_2024_005004_003_0153_01594376041 jstage_primary_article_jjphcs_50_4_50_153_article_char_ja |
| PublicationCentury | 2000 |
| PublicationDate | 2024/04/10 20240410 |
| PublicationDateYYYYMMDD | 2024-04-10 |
| PublicationDate_xml | – month: 04 year: 2024 text: 2024/04/10 day: 10 |
| PublicationDecade | 2020 |
| PublicationTitle | 医療薬学 |
| PublicationTitleAlternate | 医療薬学 |
| PublicationYear | 2024 |
| Publisher | 一般社団法人日本医療薬学会 日本医療薬学会 |
| Publisher_xml | – name: 一般社団法人日本医療薬学会 – name: 日本医療薬学会 |
| References | 2）Shepshelovich D, Leibovitch C, Klein A, Zoldan S, Milo G, Shochat T, Rozen-Zvi B, Gafter-Gvili A, Lahav M, The syndrome of inappropriate antidiuretic hormone secretion: Distribution and characterization according to etiologies, Eur J Intern Med, 2015, 26, 819-824. 17）Anwari JS, Hazazi AA, Another cause of headache after epidural injection, Neurosciences （Riyadh）, 2015, 20, 167-169. 6）Mannesse CK, Jansen PAF, Van Marum RJ, Sival RC, Kok RM, Haffmans PMJ, Egberts TCG, Characteristics, prevalence, risk factors, and underlying mechanism of hyponatremia in elderly patients treated with antidepressants: A cross-sectional study, Maturitas, 2013, 76, 357-363. 15）Müssig K, Mörike K, Häsignring HU, Severe and symptomatic hyponatremia following duloxetine treatment, J Psychopharmacol, 2009, 23, 338-339. 35）Hu D, Wurster S, Hyponatremia induced by duloxetine: A case report, Consult Pharm, 2018, 33, 446-449. 7）Hannon MJ, Thompson CJ, The syndrome of inappropriate antidiuretic hormone: Prevalence, causes and consequences, Eur J Endocrinol, 2010, 162, 5-12. 19）Demirci S, Demirci K, Altuntaș A, Söylemez A, Kutluhan S, Rapid-Onset hyponatremia induced by duloxetine in an elderly patient, New Symposium Journal, 2015, 53, 20-22. 25）Hamada T, Matsuki K, Kondou S, Furukawa S, Onji M, Duloxetine-induced Syndrome of Inappropriate Secretion of Antidiuretic Hormone in a Super-elderly Patient, Intern Med, 2022, 61, 1099-1103. 27）Sato A, Yasui-Furukori N, Oda Y, Yang M, Suzuki Y, Shinozaki M, Shimizu T, Shimoda K, Asymptomatic syndrome of inappropriate secretion of antidiuretic hormone （SIADH） following duloxetine treatment for pain with depression: Two case reports, Neuropsychopharmacol Rep, 2022, 42, 387-390. 38）Balaram M, Ford V, Townsend R, Symptomatic hyponatremia during glomerular filtration rate testing, NDT Plus, 2010, 3, 539-541. 4）Picker LV, Eede FVD, Dumont G, Moorkens G, Sabbe BGC, Antidepressants and the Risk of Hyponatremia: A Class-by-Class Review of Literature, Psychosomatics, 2014, 55, 536-547. 22）Nakamura M, Satoh Y, Hiraoka A, Fujita Y, Nagamine T, Duloxetine-induced Hyponatremia in the Elderly, CNPT, 2012, 3, 33-36. 21）Beydilli I, Akguc L, Korkmaz I, Gencoglan S, Yilmaz F, Uysal Z, Low dose duloxetine induced hyponatremia in an elderly patient: Acase report, Indian J Pharmacol, 2012, 22, 283-285. 16）Li RM, Wang C, Liu ZW, Zhao B, A case of severe hyponatremia induced by duloxetine and ziprasidone, Chin Med J （Engl）, 2012, 125, 3750-3751. 29）Ikeguchi M, Koide T, Hotta Y, Ito K, Duloxetine-induced hyponatraemia in a patient with hypocortisolaemia, J Family Med Prim Care, 2020, 9, 6282-6284. 13）Warren AM, Grossmann M, Crain MC, Russell N, Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management, Endocr Rev, 2023, 44, 819-861. 34）Kruger S, Lindstaedt M, Duloxetine and Hyponatremia: A Report of 5 Cases, J Clin Psychopharmacol, 2007, 27, 101-104. 3）Shepshelovich D, Schechter A, Calvarysky B, Diker-Cohen T, Rozen-Zvi B, Gafter-Gvili A, Medication-induced SIADH: distribution and characterization according to medication class, Br J Clin Pharmacol, 2017, 83, 1801-1807. 28）Mori M, Koide T, Imanishi Y, Matsui Y, Matsuda T, Duloxetine-induced hyponatremia in an elderly patient treated with thiazide diuretics, Indian J Pharmacol, 2014, 46, 657-659. 31）Wang D, Lai J, Lu S, Huang M, Hu S, Xu Y, Rapid-onset hyponatremia and delirium following duloxetine treatment for postherpetic neuralgia, Medicine (Baltimore) 2018, 97, e13178. doi: 10.1097/MD.0000000000013178. 33）Kulkarni M, Duloxetine induced hyponatremia, Indian J Nephrol, 2015, 25, 259. doi: 10.4103/0971-4065.151352. 40）Falhammar H, Calissendorff J, Skov J, Nathanson D, Lindh JD, Mannheimer B, Tramadol- and codeine-induced severe hyponatremia: A Swedish population-based case-control study, Eur J Intern Med, 2019, 69, 20-24. 30）Stovall R, Brahm NC, Crosby KM, Recurrent episodes of serotonin-reuptake inhibitor-mediated hyponatremia in an elderly patient, Consult Pharm, 2009, 24, 765-768. 23）Kamei S, Kaneto H, Tanabe A, Irie S, Hirata Y, Shimoda M, Kohara K, Mune T, Kaku K, Rapid onset of syndrome of inappropriate antidiuretic hormone secretion induced by duloxetine in an elderly type 2 diabetic patient with painful diabetic neuropathy, J Diabetes Investig, 2015, 6, 343-345. 11）Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ, A method for estimating the probability of adverse drug reactions, Clin Pharmacol Ther, 30, 239-245. 20）Yoshida K, Aburakawa Y, Suzuki Y, Kuroda K, Kimura T, Acute hyponatremia resulting from duloxetine-induced syndrome of inappropriate antidiuretic hormone secretion, Inter Med, 2019, 58, 1939-1942. 39）Miotto K, Cho AK, Khalil MA, Blanco K, Sasaki JD, Rawson R, Trends in Tramadol: Pharmacology, Metabolism, and Misuse, Anesth Analg, 2017, 124, 44-51. 10）Jones JK, Adverse drug reactions in the community health setting: approaches to recognizing, counseling, and reporting, Fam Community Health, 1982, 5, 58-67. 8）Takeda K, Kobayashi C, Nakai T, Oishi T, Okada A, Analysis of the Frequency and Onset Time of Hyponatremia/Syndrome of Inappropriate Antidiuretic Hormone Induced by Antidepressants or Antipsychotics, Ann Pharmacother, 2022, 56, 303-308. 1）Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, Van Der Veer S, Van Biesen W, Nagler E, Clinical practice guideline on diagnosis and treatment of hyponatraemia, Eur J Endocrinol, 2014, 170, 1-47. 42）Mannheimer B, Falhammar H, Calissendorff J, Lindh JD, Skov J, Non-thiazide diuretics and hospitalization due to hyponatraemia: A population-based case-control study, Clin Endocrinol (Oxf ), 2021, 95, 520-526. 5）Giorlando F, Teister J, Dodd S, Udina M, Berk M, Hyponatraemia: an audit of aged psychiatry patients taking SSRIs and SNRIs, Curr Drug Saf, 2013, 8, 175-180. 26）Takayama A, Nagamine T, Matsumoto Y, Nakamura M, Duloxetine and angiotensin II receptor blocker combination potentially induce severe hyponatremia in an elderly woman, Intern Med, 2019, 58, 1791-1794. 9）Marcelino GP, Collantes CMC, Oommen JK, Wang S, Baldassari H, Muralidharan R, Hanna A, Amiodarone-Induced Syndrome of Inappropriate Antidiuretic Hormone: A Case Report and Review of the Literature, P T, 2019, 44, 416-423. 32）Maramattom BV, Duloxetine-induced syndrome of inappropriate antidiuretic hormone secretion and seizures, Neurology, 2006, 66, 773-774. 18）Choi JS, Lee HW, Lee JY, Jung HY, Rapid-onset hyponatremia induced by duloxetine in a middle-aged male with depression and somatic symptoms, Psychiatry Investig, 2012, 9, 83-84. 24）Amoako AO, Brown C, Riley T, Adae D, Amoako O, Syndrome of inappropriate antidiuretic hormone secretion: a story of duloxetine-induced hyponatraemia, BMJ Case Rep, 2015, 2015, bcr2014208037. doi: 10.1136/bcr-2014-208037. 41）Knadler MP, Lobo E, Chappell J, Bergstrom R, Duloxetine: clinical pharmacokinetics and drug interactions, Clin Pharmacokinet, 2011, 50, 281-294. 37）Safdieh JE, Rudominer R, A Case of Hyponatremia Induced by Duloxetine, J Clin Psychophamacol, 2006, 26, 675-676. 12）Movig KLL, Leufkens HGM, Lenderink AW, Egberts ACG, Serotonergic antidepressants associated with an increased risk for hyponatraemia in the elderly, Eur J Clin Pharmacol, 2002, 58, 143-148. 36）Dirks AC, Helena DM, Recurrent Hyponatremia After Substitution of Citalopram With Duloxetine, J Clin Psychophamacol, 2007, 27, 313. doi: 10.1097/01.jcp.0000270086.22877.78. 14）Sun CF, Chen YL, Li YH, Kumaraswamy M, Lo YC, Chen YT, Duloxetine-Induced Hyponatremia in an Elderly Male Patient with Treatment-Refractory Major Depressive Disorder, Case Rep Psychiatry, 2019, 2019, 4109150. doi: 10.1155/2019/4109150. |
| References_xml | – reference: 39）Miotto K, Cho AK, Khalil MA, Blanco K, Sasaki JD, Rawson R, Trends in Tramadol: Pharmacology, Metabolism, and Misuse, Anesth Analg, 2017, 124, 44-51. – reference: 1）Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn EJ, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, Van Der Veer S, Van Biesen W, Nagler E, Clinical practice guideline on diagnosis and treatment of hyponatraemia, Eur J Endocrinol, 2014, 170, 1-47. – reference: 41）Knadler MP, Lobo E, Chappell J, Bergstrom R, Duloxetine: clinical pharmacokinetics and drug interactions, Clin Pharmacokinet, 2011, 50, 281-294. – reference: 25）Hamada T, Matsuki K, Kondou S, Furukawa S, Onji M, Duloxetine-induced Syndrome of Inappropriate Secretion of Antidiuretic Hormone in a Super-elderly Patient, Intern Med, 2022, 61, 1099-1103. – reference: 5）Giorlando F, Teister J, Dodd S, Udina M, Berk M, Hyponatraemia: an audit of aged psychiatry patients taking SSRIs and SNRIs, Curr Drug Saf, 2013, 8, 175-180. – reference: 17）Anwari JS, Hazazi AA, Another cause of headache after epidural injection, Neurosciences （Riyadh）, 2015, 20, 167-169. – reference: 26）Takayama A, Nagamine T, Matsumoto Y, Nakamura M, Duloxetine and angiotensin II receptor blocker combination potentially induce severe hyponatremia in an elderly woman, Intern Med, 2019, 58, 1791-1794. – reference: 10）Jones JK, Adverse drug reactions in the community health setting: approaches to recognizing, counseling, and reporting, Fam Community Health, 1982, 5, 58-67. – reference: 28）Mori M, Koide T, Imanishi Y, Matsui Y, Matsuda T, Duloxetine-induced hyponatremia in an elderly patient treated with thiazide diuretics, Indian J Pharmacol, 2014, 46, 657-659. – reference: 12）Movig KLL, Leufkens HGM, Lenderink AW, Egberts ACG, Serotonergic antidepressants associated with an increased risk for hyponatraemia in the elderly, Eur J Clin Pharmacol, 2002, 58, 143-148. – reference: 24）Amoako AO, Brown C, Riley T, Adae D, Amoako O, Syndrome of inappropriate antidiuretic hormone secretion: a story of duloxetine-induced hyponatraemia, BMJ Case Rep, 2015, 2015, bcr2014208037. doi: 10.1136/bcr-2014-208037. – reference: 16）Li RM, Wang C, Liu ZW, Zhao B, A case of severe hyponatremia induced by duloxetine and ziprasidone, Chin Med J （Engl）, 2012, 125, 3750-3751. – reference: 19）Demirci S, Demirci K, Altuntaș A, Söylemez A, Kutluhan S, Rapid-Onset hyponatremia induced by duloxetine in an elderly patient, New Symposium Journal, 2015, 53, 20-22. – reference: 7）Hannon MJ, Thompson CJ, The syndrome of inappropriate antidiuretic hormone: Prevalence, causes and consequences, Eur J Endocrinol, 2010, 162, 5-12. – reference: 15）Müssig K, Mörike K, Häsignring HU, Severe and symptomatic hyponatremia following duloxetine treatment, J Psychopharmacol, 2009, 23, 338-339. – reference: 32）Maramattom BV, Duloxetine-induced syndrome of inappropriate antidiuretic hormone secretion and seizures, Neurology, 2006, 66, 773-774. – reference: 40）Falhammar H, Calissendorff J, Skov J, Nathanson D, Lindh JD, Mannheimer B, Tramadol- and codeine-induced severe hyponatremia: A Swedish population-based case-control study, Eur J Intern Med, 2019, 69, 20-24. – reference: 6）Mannesse CK, Jansen PAF, Van Marum RJ, Sival RC, Kok RM, Haffmans PMJ, Egberts TCG, Characteristics, prevalence, risk factors, and underlying mechanism of hyponatremia in elderly patients treated with antidepressants: A cross-sectional study, Maturitas, 2013, 76, 357-363. – reference: 9）Marcelino GP, Collantes CMC, Oommen JK, Wang S, Baldassari H, Muralidharan R, Hanna A, Amiodarone-Induced Syndrome of Inappropriate Antidiuretic Hormone: A Case Report and Review of the Literature, P T, 2019, 44, 416-423. – reference: 36）Dirks AC, Helena DM, Recurrent Hyponatremia After Substitution of Citalopram With Duloxetine, J Clin Psychophamacol, 2007, 27, 313. doi: 10.1097/01.jcp.0000270086.22877.78. – reference: 14）Sun CF, Chen YL, Li YH, Kumaraswamy M, Lo YC, Chen YT, Duloxetine-Induced Hyponatremia in an Elderly Male Patient with Treatment-Refractory Major Depressive Disorder, Case Rep Psychiatry, 2019, 2019, 4109150. doi: 10.1155/2019/4109150. – reference: 31）Wang D, Lai J, Lu S, Huang M, Hu S, Xu Y, Rapid-onset hyponatremia and delirium following duloxetine treatment for postherpetic neuralgia, Medicine (Baltimore) 2018, 97, e13178. doi: 10.1097/MD.0000000000013178. – reference: 29）Ikeguchi M, Koide T, Hotta Y, Ito K, Duloxetine-induced hyponatraemia in a patient with hypocortisolaemia, J Family Med Prim Care, 2020, 9, 6282-6284. – reference: 8）Takeda K, Kobayashi C, Nakai T, Oishi T, Okada A, Analysis of the Frequency and Onset Time of Hyponatremia/Syndrome of Inappropriate Antidiuretic Hormone Induced by Antidepressants or Antipsychotics, Ann Pharmacother, 2022, 56, 303-308. – reference: 11）Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ, A method for estimating the probability of adverse drug reactions, Clin Pharmacol Ther, 30, 239-245. – reference: 3）Shepshelovich D, Schechter A, Calvarysky B, Diker-Cohen T, Rozen-Zvi B, Gafter-Gvili A, Medication-induced SIADH: distribution and characterization according to medication class, Br J Clin Pharmacol, 2017, 83, 1801-1807. – reference: 22）Nakamura M, Satoh Y, Hiraoka A, Fujita Y, Nagamine T, Duloxetine-induced Hyponatremia in the Elderly, CNPT, 2012, 3, 33-36. – reference: 27）Sato A, Yasui-Furukori N, Oda Y, Yang M, Suzuki Y, Shinozaki M, Shimizu T, Shimoda K, Asymptomatic syndrome of inappropriate secretion of antidiuretic hormone （SIADH） following duloxetine treatment for pain with depression: Two case reports, Neuropsychopharmacol Rep, 2022, 42, 387-390. – reference: 21）Beydilli I, Akguc L, Korkmaz I, Gencoglan S, Yilmaz F, Uysal Z, Low dose duloxetine induced hyponatremia in an elderly patient: Acase report, Indian J Pharmacol, 2012, 22, 283-285. – reference: 18）Choi JS, Lee HW, Lee JY, Jung HY, Rapid-onset hyponatremia induced by duloxetine in a middle-aged male with depression and somatic symptoms, Psychiatry Investig, 2012, 9, 83-84. – reference: 35）Hu D, Wurster S, Hyponatremia induced by duloxetine: A case report, Consult Pharm, 2018, 33, 446-449. – reference: 42）Mannheimer B, Falhammar H, Calissendorff J, Lindh JD, Skov J, Non-thiazide diuretics and hospitalization due to hyponatraemia: A population-based case-control study, Clin Endocrinol (Oxf ), 2021, 95, 520-526. – reference: 2）Shepshelovich D, Leibovitch C, Klein A, Zoldan S, Milo G, Shochat T, Rozen-Zvi B, Gafter-Gvili A, Lahav M, The syndrome of inappropriate antidiuretic hormone secretion: Distribution and characterization according to etiologies, Eur J Intern Med, 2015, 26, 819-824. – reference: 30）Stovall R, Brahm NC, Crosby KM, Recurrent episodes of serotonin-reuptake inhibitor-mediated hyponatremia in an elderly patient, Consult Pharm, 2009, 24, 765-768. – reference: 37）Safdieh JE, Rudominer R, A Case of Hyponatremia Induced by Duloxetine, J Clin Psychophamacol, 2006, 26, 675-676. – reference: 33）Kulkarni M, Duloxetine induced hyponatremia, Indian J Nephrol, 2015, 25, 259. doi: 10.4103/0971-4065.151352. – reference: 23）Kamei S, Kaneto H, Tanabe A, Irie S, Hirata Y, Shimoda M, Kohara K, Mune T, Kaku K, Rapid onset of syndrome of inappropriate antidiuretic hormone secretion induced by duloxetine in an elderly type 2 diabetic patient with painful diabetic neuropathy, J Diabetes Investig, 2015, 6, 343-345. – reference: 34）Kruger S, Lindstaedt M, Duloxetine and Hyponatremia: A Report of 5 Cases, J Clin Psychopharmacol, 2007, 27, 101-104. – reference: 13）Warren AM, Grossmann M, Crain MC, Russell N, Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management, Endocr Rev, 2023, 44, 819-861. – reference: 38）Balaram M, Ford V, Townsend R, Symptomatic hyponatremia during glomerular filtration rate testing, NDT Plus, 2010, 3, 539-541. – reference: 4）Picker LV, Eede FVD, Dumont G, Moorkens G, Sabbe BGC, Antidepressants and the Risk of Hyponatremia: A Class-by-Class Review of Literature, Psychosomatics, 2014, 55, 536-547. – reference: 20）Yoshida K, Aburakawa Y, Suzuki Y, Kuroda K, Kimura T, Acute hyponatremia resulting from duloxetine-induced syndrome of inappropriate antidiuretic hormone secretion, Inter Med, 2019, 58, 1939-1942. |
| SSID | ssib003116159 ssib002484604 ssib000871962 ssib060196744 ssj0069027 ssib005902156 ssib023157658 |
| Score | 2.3826067 |
| Snippet | 「緒言」抗利尿ホルモン不適合分泌症候群(syndrome of inappropriate antidiuretic hormone secretion: SIADH)は, 抗利尿ホルモン(antidiuretic hormone:... |
| SourceID | medicalonline jstage |
| SourceType | Publisher |
| StartPage | 153 |
| SubjectTerms | duloxetine hyponatremia risk factor syndrome of inappropriate antidiuretic hormone secretion |
| Title | デュロキセチン投与後に抗利尿ホルモン不適合分泌症候群をきたした慢性腰痛症の1例 |
| URI | https://www.jstage.jst.go.jp/article/jjphcs/50/4/50_153/_article/-char/ja http://mol.medicalonline.jp/library/journal/download?GoodsID=db5pharm/2024/005004/003&name=0153-0159j |
| Volume | 50 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 医療薬学, 2024/04/10, Vol.50(4), pp.153-159 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1882-1499 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0069027 issn: 1346-342X databaseCode: KQ8 dateStart: 20010101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9RAEA-lvggifmL94h5Mn3o1n5vdN5O7HEVBKrTQt5DkcsiBtXjtQ33qNdSW2ooIckgfhKJIKUqhLwWh_jHpXfW_cGZ3c5eKUD8g7A2bycxvZzfZmb3NRFHuhKyRaGHMynbDDstWTPA5SMJyw4EwLmR6FIU82-dDMjFt3Z-xZ4aGw8KupYX5aDx-_tv3Sv6lV6EO-hXfkv2Lnu0LhQqgoX-hhB6G8o_6WPVNlcLhSMK1c6LKCWNAeF7OrEvCM1WfqNRVGVxlqR5Vqa_6tur5Kq1wHl11vZzHwVOUqi7jPJrq1aQclkt2-4RRUCEkAwzGBfLLmYaihEBKUAVwolIHFVGhS1MZwxrA41qyFcyQwGhVEqyWE06hBjDbHAZBOS6colgDsIUKxNzXJVrq6xwrNN4rOuwcSoWbz0FAAAJkMaK6FTwF9nX7a5u8gh9oImCv4gDmtTVQWWQDJJTjZD7C4GxwAQAQMKpgkdP4JRsnPNU9wc8quR0Asif4KTKjUWyU5RnFBR-D7xOSW3_xFs07TuOmo7y5DnaExwcJQ4Wy4-T4cfFAhA63AEEMwkin2Y9fDoDdwgxpWqRsWsaMcCBEHYZpEGqz4rQq8gnLx4dVmCN1kR1aulu6SAj_60xuEwsT4Tabc4_j1riNK6DmwGXpbySVt14g-AJbCywsgDnIT-Hbi0ETQqgzhkMIfuTkwaNiBOLAHFTYWGCBQ15YoTB1DIkKGe4YOsl9Dx6iIwjYBxsLCKab4h-UEM4gAXb-fafcaiLNL7bu7om2gQPchHAQ83yceyL-ohWpcgre7tQF5bwMU0uuaN1FZagZXlJGJ0We-8Wx0tTgtc3WWGm0NDnIgL94WWll6WqWfszSz9kyHF-ztJ2l-731t0cHr7qHG1l7t7fe6a7tdPe-ZelWlu5m6TYwHB1s_mjvdF-vddde9PY3jjur3aV3x4cfsuU3WXsza7_P2h0oeyvbvaVP31f2jjtbwJO1v-hHhy-vKNM1f6oyUZZfdyk3DUL1Mksa9TrDfMZOAhG-TRu204ghfAaTg10t2gjrSUxiUjdimDGS2DDikBE9hgg2JISaV5Xh2aezyTWlFLEk0aiFS-qmFTkmTbS6iYk0IXpNojAeUZgwbjAnUvgEfz5uRpR7J_ojkM__VlCP7Dk0boA3aYCJtDT8MQMNxUDBLNxxaOnX_0P9DeXs4BlwUxmef7aQ3IIwaD66zQfyT28oKCA |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E3%83%87%E3%83%A5%E3%83%AD%E3%82%AD%E3%82%BB%E3%83%81%E3%83%B3%E6%8A%95%E4%B8%8E%E5%BE%8C%E3%81%AB%E6%8A%97%E5%88%A9%E5%B0%BF%E3%83%9B%E3%83%AB%E3%83%A2%E3%83%B3%E4%B8%8D%E9%81%A9%E5%90%88%E5%88%86%E6%B3%8C%E7%97%87%E5%80%99%E7%BE%A4%E3%82%92%E3%81%8D%E3%81%9F%E3%81%97%E3%81%9F%E6%85%A2%E6%80%A7%E8%85%B0%E7%97%9B%E7%97%87%E3%81%AE1%E4%BE%8B&rft.jtitle=%E5%8C%BB%E7%99%82%E8%96%AC%E5%AD%A6&rft.au=%E5%A5%A5%E5%B7%9D%2C+%E5%AF%9B&rft.au=%E5%B0%8F%E6%9E%97%2C+%E7%94%B1%E4%BD%B3&rft.au=%E5%B0%8F%E6%9E%97%2C+%E4%BD%B3%E4%BB%A3&rft.au=%E5%9C%9F%E6%89%8B%2C+%E8%B3%A2%E5%8F%B2&rft.date=2024-04-10&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA%E6%97%A5%E6%9C%AC%E5%8C%BB%E7%99%82%E8%96%AC%E5%AD%A6%E4%BC%9A&rft.issn=1346-342X&rft.eissn=1882-1499&rft.volume=50&rft.issue=4&rft.spage=153&rft.epage=159&rft_id=info:doi/10.5649%2Fjjphcs.50.153&rft.externalDocID=article_jjphcs_50_4_50_153_article_char_ja |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1346-342X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1346-342X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1346-342X&client=summon |